These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21949890)

  • 1. Resolution of praziquantel.
    Woelfle M; Seerden JP; de Gooijer J; Pouwer K; Olliaro P; Todd MH
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1260. PubMed ID: 21949890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer).
    Olliaro P; Delgado-Romero P; Keiser J
    J Antimicrob Chemother; 2014 Apr; 69(4):863-70. PubMed ID: 24390933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress of research on preparation and application of praziquantel].
    Wu DZ; Ma Z; Liu YF; Zhu WF; Ning A
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Apr; 25(2):194-6. PubMed ID: 23894845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment.
    Meyer T; Sekljic H; Fuchs S; Bothe H; Schollmeyer D; Miculka C
    PLoS Negl Trop Dis; 2009; 3(1):e357. PubMed ID: 19159015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance.
    Doenhoff MJ; Pica-Mattoccia L
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):199-210. PubMed ID: 16597202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCR synthesis of praziquantel derivatives.
    Liu H; William S; Herdtweck E; Botros S; Dömling A
    Chem Biol Drug Des; 2012 Apr; 79(4):470-7. PubMed ID: 22151001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantification method for determination of racemate praziquantel and R-enantiomer in rat plasma for comparison of their pharmacokinetics.
    Zhang D; Wang H; Ji J; Nie L; Sun D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():64-69. PubMed ID: 28222334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open science is a research accelerator.
    Woelfle M; Olliaro P; Todd MH
    Nat Chem; 2011 Sep; 3(10):745-8. PubMed ID: 21941234
    [No Abstract]   [Full Text] [Related]  

  • 9. Praziquantel and schistosomiasis.
    Dömling A; Khoury K
    ChemMedChem; 2010 Sep; 5(9):1420-34. PubMed ID: 20677314
    [No Abstract]   [Full Text] [Related]  

  • 10. The Mechanism of Action of Praziquantel: Six Hypotheses.
    Thomas CM; Timson DJ
    Curr Top Med Chem; 2018; 18(18):1575-1584. PubMed ID: 30370849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of a new antischistosomally active and toxicologically tolerant C-12 monothione surrogate of the universal antihelmintic praziquantel.
    Abo-Ghalia MH; Soliman AM
    Acta Pol Pharm; 2002; 59(4):313-20. PubMed ID: 12403307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational polymorphic changes in the crystal structure of the chiral antiparasitic drug praziquantel and interactions with calcium carbonate.
    Borrego-Sánchez A; Carazo E; Albertini B; Passerini N; Perissutti B; Cerezo P; Viseras C; Hernández-Laguna A; Aguzzi C; Sainz-Díaz CI
    Eur J Pharm Biopharm; 2018 Nov; 132():180-191. PubMed ID: 30267834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparticulate system combining taste masking and immediate release properties for the aversive compound praziquantel.
    Münster M; Schoch C; Schmidt C; Breitkreutz J
    Eur J Pharm Sci; 2017 Nov; 109():446-454. PubMed ID: 28887230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the mechanism of action of praziquantel and how might resistance strike?
    Cupit PM; Cunningham C
    Future Med Chem; 2015; 7(6):701-5. PubMed ID: 25996063
    [No Abstract]   [Full Text] [Related]  

  • 15. Praziquantel: An Enigmatic, Yet Effective, Drug.
    Timson DJ
    Methods Mol Biol; 2020; 2151():1-8. PubMed ID: 32451991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into Praziquantel Metabolism and Potential Enantiomeric Cytochrome P450-Mediated Drug-Drug Interaction.
    Vendrell-Navarro G; Scheible H; Lignet F; Burt H; Luepfert C; Marx A; Abla N; Swart P; Perrin D
    Drug Metab Dispos; 2020 Jun; 48(6):481-490. PubMed ID: 32193358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An explorative analysis of process and formulation variables affecting comilling in a vibrational mill: The case of praziquantel.
    Beatrice Perissutti ; Passerini N; Trastullo R; Keiser J; Zanolla D; Zingone G; Voinovich D; Albertini B
    Int J Pharm; 2017 Nov; 533(2):402-412. PubMed ID: 28552799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid lipid extrusion with small die diameters--electrostatic charging, taste masking and continuous production.
    Witzleb R; Kanikanti VR; Hamann HJ; Kleinebudde P
    Eur J Pharm Biopharm; 2011 Jan; 77(1):170-7. PubMed ID: 20940049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theoretical and experimental study of a praziquantel and beta-cyclodextrin inclusion complex using molecular mechanic calculations and H1-nuclear magnetic resonance.
    de Jesus MB; de Matos Alves Pinto L; Fraceto LF; Takahata Y; Lino AC; Jaime C; de Paula E
    J Pharm Biomed Anal; 2006 Jun; 41(4):1428-32. PubMed ID: 16678375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the usefulness of cross dehydrogenative coupling reactions with a removable protecting group.
    Tsang AS; Ingram K; Keiser J; Hibbert DB; Todd MH
    Org Biomol Chem; 2013 Aug; 11(30):4921-4. PubMed ID: 23820826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.